Arrow-right Camera

The Spokesman-Review Newspaper The Spokesman-Review

Wednesday, October 23, 2019  Spokane, Washington  Est. May 19, 1883
Clear Day 39° Clear
News >  Pacific NW

Montana seeks marketing injunction against OxyContin maker

OxyContin pills are arranged Feb. 19, 2013, for a photo at a pharmacy in Montpelier, Vt. The state of Montana is seeking a preliminary injunction to prevent the maker of the powerful painkiller OxyContin from marketing opioids to Montana prescribers, seeking to put the force of a court order behind Purdue Pharma's recent promise to end such marketing nationwide. (Toby Talbot / AP)
OxyContin pills are arranged Feb. 19, 2013, for a photo at a pharmacy in Montpelier, Vt. The state of Montana is seeking a preliminary injunction to prevent the maker of the powerful painkiller OxyContin from marketing opioids to Montana prescribers, seeking to put the force of a court order behind Purdue Pharma's recent promise to end such marketing nationwide. (Toby Talbot / AP)
Associated Press

HELENA – The state of Montana is seeking a preliminary injunction to prevent the maker of the powerful painkiller OxyContin from marketing opioids to Montana prescribers, seeking to put the force of a court order behind Purdue Pharma’s recent promise to end such marketing nationwide.

Purdue announced Feb. 10 it would stop marketing opioid drugs to doctors in response to lawsuits by several states alleging the company misrepresented the risk of addiction.

The company last week declined Montana’s request to put that decision into an enforceable agreement. Attorney General Tim Fox filed a motion for the injunction on Tuesday in Helena.

Purdue spokesman Robert Josephson said Wednesday a written agreement is unnecessary.

The requested injunction would prohibit direct marketing to Montana prescribers while the state’s consumer protection lawsuit against Purdue moves forward.

Subscribe to the Morning Review newsletter

Get the day’s top headlines delivered to your inbox every morning by subscribing to our newsletter.

You have been successfully subscribed!
There was a problem subscribing you to the newsletter. Double check your email and try again, or email webteam@spokesman.com